Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: A comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 7, 2007, Pages 1012-1017

  Urhan, Muammer ^a   Dadparvar, Simin ^a   Mavi, Ayse ^a   Houseni, Mohamed ^a   Chamroonrat, Wichana ^a   Alavi, Abass ^a   Mandel, Susan J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

131I whole body scintigraphy; Thyroid cancer

Indexed keywords

IODINE 123; IODINE 131; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34250378348     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0341-x     Document Type: Article

References (17)

1. Tsang RW, Brierly JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutchliffe SB. The effects of surgery, radioiodine and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998;82:375-88.
2. Coburn M, Teates D, Wanebo HJ. Recurrent thyroid cancer. Role of surgery vs. radioactive iodine. Ann Surg 1994;219:587-95.
3. Park HM. The stunning effect in radioiodine therapy of thyroid cancer. In: Freeman L, editors. Nuclear medicine annals. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p 49-67.
4. Leger FA, Izembart M, Dagousset F, Barritault L, Baillet G, Chevalier A, et al. Decreased uptake of therapeutic doses of I-131 after 185 MBq I-131 diagostic imaging for thyroid remnants in differentiated thyroid carcinoma. Eur J Nucl Med 1998;25:242-6.
5. Mandel SJ, Shankar LK, Benard F, Yamamoto A, Alavi A. Superiority of I-123 compared with I-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med 2001;26 1:6-9.
6. Yaakob W, Gordon L, Spicer KM, Nitke SJ. The usefulness of I-123 whole-body scans in evaluating thyroid carcinoma and metastases. J Nucl Med Technol 1999;27:279-81.
7. Shankar LK, Yamamoto AJ, Alavi A, Mandel SJ. Comparison of I-123 scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer. J Nucl Med 2002;43:72-6.
8. Gerard SK, Cavalieri RR. I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24 and 48 hours. Clin Nucl Med 2001;27:1-8.
9. Alzahrani AS, Bakheet S, Al Mandil M, Al-Hajjaj A, Almahfouz A, Al Haj A. I-123 isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: a comparison with post I-131 therapy whole-body scanning. J Clin Endocrin Metab 2001;86:5294-300.
10. Sherman SI, Tielens ET, Sostre S, Wharam MD Jr, Ladenson PW. Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994;78:629-34.
11. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrin Metab 1986;63:960-7.
12. Sisson JC, Giordano TJ, Jamadar DA, Kazerooni EA, Shapiro B, Gross MD, et al. I-131 treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer 1996;78:2184-92.
13. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39:1531-6.
14. Hilditch TE, Dempsey MF, Bolster AA, McMenemin RM, Reed NS. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic I-131 and I-123. Eur J Nucl Med Mol Imaging 2002;29:783-8.
15. Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C, et al. Therapeutic doses of I-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-91.
16. Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995;80:1488-92.
17. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988;29:1790-4.